| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Purchase of treasury stock | - | 0 |
| Net cash provided by financing activities | 2,728,880 | 2,093,958 |
| Net increase in cash and cash equivalents | 11,828 | 427,873 |
| Cash and cash equivalents at beginning of period | 3,905,799 | - |
| Cash and cash equivalents at end of period | 3,917,627 | - |
Silo Pharma, Inc. (SILO)
Silo Pharma, Inc. (SILO)